Table 2.
Follicular maturation, ovulation, endometrial thickness, and chemical and clinical pregnancies of the 2 studied groups after crossover of ovulation induction medication
| Variables | C/S group n = 216 (%) | CC group n = 216 (%) | p-value (95% CI) | |
|---|---|---|---|---|
| Follicular Maturation | 63 (43.4) | 38 (30.2) | 0.02* | |
| Ovulation | 60 (41.4) | 36 (28.6) | 0.02* | |
| Endometrial thickness [mm] | 9.1 ±1.3 | 8.2 ±1.1 | 0.007* (–0.33, –0.1, 0.13) | |
| Chemical pregnancy | ||||
| Positive | 53 (36.6) | 30 (23.8) | 0.02* | |
| Negative | 92 (63.4) | 96 (76.2) | ||
| Clinical pregnancy | ||||
| Positive | 48 (33.1) | 26 (20.6) | 0.01* | |
| Negative | 97 (66.9) | 100 (79.4) | ||
*
Significant
CC group – clomiphene citrate group, CI – confidence interval, C/S group – clomiphene/sildenafil group
Data presented as number and percentage (%) and mean ±SD (standard deviation).
Independent t-test used for statistical analysis when data presented as mean ±SD.
Chi-square (χ2) test used for statistical analysis when data presented as number and percentage.